Page last updated: 2024-08-17

triamcinolone acetonide and Cranial Nerve II Injuries

triamcinolone acetonide has been researched along with Cranial Nerve II Injuries in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CH; Huang, TL; Lin, KH; Sheu, MM; Tsai, RK1

Other Studies

1 other study(ies) available for triamcinolone acetonide and Cranial Nerve II Injuries

ArticleYear
Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats.
    Experimental eye research, 2011, Volume: 92, Issue:2

    Topics: Administration, Topical; Animals; Blotting, Western; Cell Count; Ectodysplasins; Evoked Potentials, Visual; Extracellular Signal-Regulated MAP Kinases; Glucocorticoids; In Situ Nick-End Labeling; Injections, Intraperitoneal; Methylprednisolone Hemisuccinate; Nerve Crush; Nerve Degeneration; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Proto-Oncogene Proteins c-akt; Rats; Retinal Ganglion Cells; STAT3 Transcription Factor; Triamcinolone Acetonide

2011